Beta Drugs Shareholding Pattern & Promoter Holding
Pharmaceuticals & Biotechnology · Latest pattern: Sep 2026
As of Sep 2026, promoters hold 58.91% of Beta Drugs, FIIs hold 1.37%, DIIs hold 6.45% and the public holds 33.27%. Promoter holding fell by 0.19 percentage points from Jun 2026.
Get an alert when Beta Drugs reports results or its shareholding changes. Free account.
Promoters
58.91%
−0.19 pp QoQ
FIIs
1.37%
+0.35 pp QoQ
DIIs
6.45%
+0.22 pp QoQ
Public
33.27%
−0.38 pp QoQ
Beta Drugs shareholding, quarter by quarter
| Quarter | Promoters | FIIs | DIIs | Public | Shareholders |
|---|---|---|---|---|---|
| Sep 2026 | 58.91% | 1.37% | 6.45% | 33.27% | 10,145 |
| Jun 2026 | 59.10% | 1.02% | 6.23% | 33.65% | 7,359 |
| Mar 2026 | 64.63% | 1.16% | 2.15% | 32.06% | 4,736 |
| Dec 2025 | 64.90% | 1.14% | 1.90% | 32.07% | 3,694 |
| Sep 2025 | 66.73% | 0.90% | 0.29% | 32.07% | 3,184 |
| Jun 2025 | 66.73% | 0.90% | 0.26% | 32.11% | 3,139 |
| Mar 2025 | 66.73% | 0.90% | 0.17% | 32.20% | 3,054 |
| Dec 2024 | 66.73% | 1.15% | 0.17% | 31.95% | 2,882 |
| Sep 2024 | 66.73% | 1.16% | 0.16% | 31.95% | 2,567 |
| Jun 2024 | 66.73% | 0.90% | 0.12% | 32.25% | 2,323 |
| Mar 2024 | 66.73% | 0.32% | 0.06% | 32.87% | 2,116 |
| Dec 2023 | 66.73% | 0.32% | 0.02% | 32.92% | 1,928 |
Promoters · FIIs (foreign institutions) · DIIs (domestic institutions) · Public (retail & others). Percentages of total shares, from the quarterly pattern filed with the exchanges.
Value of the promoter stake
At a market capitalisation of ₹2.02k cr, the promoter group's 58.91% stake is worth ₹1.19k cr. A promoter group is usually a family, trust or holding company; this figure covers only this listed company and is not anyone's net worth.
Promoter holding in Pharmaceuticals & Biotechnology peers
Beta Drugs shareholding: common questions
What is the promoter holding in Beta Drugs?
Promoters hold 58.91% of Beta Drugs as of Sep 2026. Their stake fell by 0.19 percentage points from Jun 2026.
How much do FIIs hold in Beta Drugs?
Foreign institutional investors (FIIs) held 1.37% of Beta Drugs in Sep 2026, +0.35 pp versus Jun 2026.
How much do mutual funds and other DIIs hold in Beta Drugs?
Domestic institutional investors (DIIs), which include mutual funds and insurers, held 6.45% of Beta Drugs in Sep 2026, +0.22 pp versus Jun 2026.
Is the promoter holding in Beta Drugs pledged?
The latest disclosed shareholding pattern shows no pledged promoter shares in Beta Drugs.
How has Beta Drugs's promoter holding changed in the last year?
Promoter holding moved from 66.73% in Sep 2025 to 58.91% in Sep 2026 (−7.82 pp).
How many shareholders does Beta Drugs have?
Beta Drugs had 10,145 shareholders in Sep 2026, compared with 7,359 in Jun 2026.